Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Economic costs of childhood lead exposure in low- and middle-income countries.

Attina TM, Trasande L.

Environ Health Perspect. 2013 Sep;121(9):1097-102. doi: 10.1289/ehp.1206424. Epub 2013 Jun 25.

2.

Childhood lead exposure in France: benefit estimation and partial cost-benefit analysis of lead hazard control.

Pichery C, Bellanger M, Zmirou-Navier D, Glorennec P, Hartemann P, Grandjean P.

Environ Health. 2011 May 20;10:44. doi: 10.1186/1476-069X-10-44.

3.

Schooling and wage income losses due to early-childhood growth faltering in developing countries: national, regional, and global estimates.

Fink G, Peet E, Danaei G, Andrews K, McCoy DC, Sudfeld CR, Smith Fawzi MC, Ezzati M, Fawzi WW.

Am J Clin Nutr. 2016 Jul;104(1):104-12. doi: 10.3945/ajcn.115.123968.

PMID:
27357091
4.

The burden of disease from pediatric lead exposure at hazardous waste sites in 7 Asian countries.

Caravanos J, Chatham-Stephens K, Ericson B, Landrigan PJ, Fuller R.

Environ Res. 2013 Jan;120:119-25. doi: 10.1016/j.envres.2012.06.006. Epub 2012 Sep 20.

PMID:
22999658
6.

Health impact assessment and monetary valuation of IQ loss in pre-school children due to lead exposure through locally produced food.

Bierkens J, Buekers J, Van Holderbeke M, Torfs R.

Sci Total Environ. 2012 Jan 1;414:90-7. doi: 10.1016/j.scitotenv.2011.10.048. Epub 2011 Dec 2.

PMID:
22137649
7.

Global Economic Burden of Norovirus Gastroenteritis.

Bartsch SM, Lopman BA, Ozawa S, Hall AJ, Lee BY.

PLoS One. 2016 Apr 26;11(4):e0151219. doi: 10.1371/journal.pone.0151219. eCollection 2016.

8.

Economic impacts of environmentally attributable childhood health outcomes in the European Union.

Bartlett ES, Trasande L.

Eur J Public Health. 2014 Feb;24(1):21-6. doi: 10.1093/eurpub/ckt063. Epub 2013 Jun 6.

PMID:
23748596
9.

Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.

Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L.

J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66. doi: 10.1210/jc.2014-4323. Epub 2015 Mar 5.

10.

Global economic cost of smoking-attributable diseases.

Goodchild M, Nargis N, Tursan d'Espaignet E.

Tob Control. 2018 Jan;27(1):58-64. doi: 10.1136/tobaccocontrol-2016-053305. Epub 2017 Jan 30.

11.

Low-level environmental lead exposure and children's intellectual function: an international pooled analysis.

Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, Canfield RL, Dietrich KN, Bornschein R, Greene T, Rothenberg SJ, Needleman HL, Schnaas L, Wasserman G, Graziano J, Roberts R.

Environ Health Perspect. 2005 Jul;113(7):894-9.

12.

The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.

Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA.

Ophthalmology. 2015 Aug;122(8):1706-10.

13.

Indirect cost of maternal deaths in the WHO African Region in 2010.

Kirigia JM, Mwabu GM, Orem JN, Muthuri RD.

BMC Pregnancy Childbirth. 2014 Aug 31;14:299. doi: 10.1186/1471-2393-14-299.

14.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
15.

The pediatric burden of disease from lead exposure at toxic waste sites in low and middle income countries.

Chatham-Stephens K, Caravanos J, Ericson B, Landrigan P, Fuller R.

Environ Res. 2014 Jul;132:379-83. doi: 10.1016/j.envres.2014.04.018. Epub 2014 May 21.

PMID:
24853976
16.

Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis.

Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon JP, Myers JP, DiGangi J, Zoeller RT, Trasande L.

Lancet Diabetes Endocrinol. 2016 Dec;4(12):996-1003. doi: 10.1016/S2213-8587(16)30275-3. Epub 2016 Oct 17.

PMID:
27765541
17.

Testing the dose-response specification in epidemiology: public health and policy consequences for lead.

Rothenberg SJ, Rothenberg JC.

Environ Health Perspect. 2005 Sep;113(9):1190-5.

18.

Economic implications of mercury exposure in the context of the global mercury treaty: Hair mercury levels and estimated lost economic productivity in selected developing countries.

Trasande L, DiGangi J, Evers DC, Petrlik J, Buck DG, Šamánek J, Beeler B, Turnquist MA, Regan K.

J Environ Manage. 2016 Dec 1;183:229-235. doi: 10.1016/j.jenvman.2016.08.058. Epub 2016 Sep 2.

PMID:
27594689
19.

One world, one hope: the cost of providing antiretroviral therapy to all nations.

Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.

AIDS. 1998 Nov 12;12(16):2203-9.

PMID:
9833862
20.

Expanding global access to radiotherapy.

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M.

Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. Review.

PMID:
26419354

Supplemental Content

Support Center